Finanzwire Finanzwire
Basculer en Français
9797 Companies
196384 Keywords
127399 Articles
104412 Press releases
Headlines Articles Press releases Morphogenesis Inc. Remove
  1. Home
  2. Companies
  3. Morphogenesis Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/25/2024 at 15:05, 1 year 9 months ago

    TuHURA Biosciences to Showcase Clinical Trial Results at ASCO 2024

    Clinical Trials Mergers And Acquisitions TuHURA Biosciences Cancer Immunotherapy ASCO 2024
  • PRESS RELEASE

    published on 04/25/2024 at 15:00, 1 year 9 months ago

    TuHURA Biosciences to Present Its IFx-2.0 Personalized Cancer Vaccine Clinical Trial Results at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

    TuHURA Biosciences, Inc. announces IFx-2.0 Phase 1b trial results accepted for poster presentation at 2024 ASCO Annual Meeting. Company to form new entity with Kintara Therapeutics, Inc. and focus on cancer vaccines and bi-functional ADCs
    Phase 1b Trial TuHURA Biosciences Inc. IFx-2.0 Poster Presentation Kintara Therapeutics Inc.
    Logo of Morphogenesis Inc.
  • PRESS RELEASE

    published on 12/14/2023 at 16:00, 2 years 1 month ago

    Morphogenesis, Inc. Announces Corporate Rebranding to TuHURA Biosciences, Inc. and Provides a Business Overview

    Logo of Morphogenesis Inc.
  • PRESS RELEASE

    published on 11/08/2023 at 15:00, 2 years 2 months ago

    Morphogenesis, Inc. Biomarker Analysis Data from IFx-Hu2.0 in Melanoma Refractory to Anti-PD1-Based Therapies Demonstrates Ability to Overcome Primary Resistance to Checkpoint Inhibitors and Trigger an Innate Immune Response

    Logo of Morphogenesis Inc.
Accesswire
  • Published on 02/04/2026 at 02:15, 4 hours 47 minutes ago

    Future Fuels Announces $2 Million LIFE Flow-Through Offering

  • Published on 02/04/2026 at 00:00, 7 hours 2 minutes ago

    Sintana Energy Inc. Announces VMM-37 Resolution

  • Published on 02/03/2026 at 23:30, 7 hours 32 minutes ago

    FutureGen Industries Retains Market-Making Services

  • Published on 02/03/2026 at 23:12, 7 hours 50 minutes ago

    Appointment of Credit Advisor for Stage 1 Operations

  • Published on 02/03/2026 at 22:30, 8 hours 32 minutes ago

    Green Bridge Announces Closing of Non-Brokered Private Placement for Gross Proceeds of C$4 Million

View all ACCESSWIRE
EQS Group
  • Published on 02/04/2026 at 06:30, 32 minutes ago

    Avolta's FY 2025 Results Invitation

  • Published on 02/04/2026 at 02:05, 4 hours 57 minutes ago

    Saudi Arabia Preparing for AlUla Emerging Market Economies Conference to be Held February 8-9, 2026

  • Published on 02/04/2026 at 00:42, 6 hours 19 minutes ago

    EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3X - Initial Director's Interest Notice

  • Published on 02/03/2026 at 20:57, 10 hours 5 minutes ago

    EQS-Adhoc: tick Trading Software AG adjusts forecast for the current 2025/2026 fiscal year

  • Published on 02/03/2026 at 20:05, 10 hours 57 minutes ago

    KHUFU'S IN EGYPT NAMED NO.1 AT MIDDLE EAST & NORTH AFRICA'S 50 BEST RESTAURANTS 2026

View all EQS
Les Echos
  • Published on 02/03/2026 at 17:45, 13 hours 17 minutes ago

    Revenue growth in 2025 to €11.2m (+5%)

  • Published on 02/03/2026 at 08:00, 23 hours 2 minutes ago

    EURAZEO & PANTHEON ESTABLISH A NEARLY €500 MILLION PRIVATE DEBT CONTINUATION VEHICLE

  • Published on 02/03/2026 at 08:00, 23 hours 2 minutes ago

    Neoen launches three new solar farms in France with a total capacity of 230 MWp

  • Published on 02/02/2026 at 18:23, 1 day 12 hours ago

    Monthly disclosure of the total number of shares and voting rights - January 2026

  • Published on 02/02/2026 at 18:00, 1 day 13 hours ago

    Covivio - Information on total number of voting rights and share capital

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy